The Knowledge Group Has Scheduled a Live Webcast on TKG’s Paragraph IV Patent Litigation in the 2019 Landscape:Trends and Significant Developments Explored
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, announced today that it has scheduled a live webcast entitled: The Knowledge Group’s Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored! This 1-hour event is scheduled on Wednesday, April 10, 2019 from 3:00 PM to 4:00 PM (ET).
- (1888PressRelease) March 16, 2019 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, announced today that it has scheduled a live webcast entitled: The Knowledge Group’s Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored! This 1-hour event is scheduled on Wednesday, April 10, 2019 from 3:00 PM to 4:00 PM (ET).
Event Synopsis:
In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the likelihood of a PIV lawsuit.
In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.
Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Litigation. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape.
Key issues that will be covered in this course are:
• Paragraph IV Patent Litigation and the Abbreviated New Drug Application (ANDA): Recent Trends and Developments
• Notable PIV Cases and Court Rulings
• Best Application Strategies
• Significant Litigation Techniques
• What Lies Ahead
Speakers/Faculty Panel:
Buchanan Ingersoll & Rooney PC
Mr. Philip L. Hirschhorn
Shareholder
Polsinelli PC
Mr. Luke T. Shannon
Shareholder
For an updated list of the faculty panel, please visit:
https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-certifications-2/
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group brings together the world's leading authorities and industry participants through informative webcasts that study the impact of changing regulations and help businesses succeed through proper regulatory compliance.
Visit http://theknowledgegroup.org/ for further information and inquiry.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam